Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Blood|December 21, 2006
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemiasIvana Gojo, Anchalee Jiemjit, Jane B Trepel, et al.Scientific Reports|May 23, 2022
NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59Sung Wook Son, Eunho Cho, Hanbyoul Cho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphomaQin C Ryan, Donna Headlee, Milin Acharya, et al.Blood|July 20, 2002
Regulation of leukemic cell adhesion, proliferation, and survival by beta-cateninEun Joo Chung, Sang-Gu Hwang, PhuongMai Nguyen, et al.Cancer Biology & Therapy|September 3, 2005
A phase II study of perifosine in androgen independent prostate cancerEdwin M Posadas, James Gulley, Philip M Arlen, et al.Heliyon|March 12, 2024
Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategyMin Joo Choi, Hakjun Hyun, Jung Yeon Heo, et al.Journal of Medical Virology|December 6, 2023
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicityJinyoung Yang, Hye-Jin Kim, Jun-Won Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignanciesShivaani Kummar, Martin Gutierrez, Erin R Gardner, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathwayJoon-Yong Chung, Hima Makala, Woonghee Lee, et al.Microbiology Spectrum|September 26, 2023
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022Young Jae Lee, Ju-Yeon Choi, Jinyoung Yang, et al.Pageof 10